Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Built To Grow Fitness Business

The Ozempic Effect

08 Aug 2023

Description

In recent times, there has been a buzz around a weight loss drug called Ozempic, touted as the "magic pill" for effortless weight loss.This drug, originally designed to treat diabetes by lowering A1C levels, has inadvertently become a sought-after solution for rapid weight loss.The allure of a quick and easy fix has led many to believe that taking an injection once a week will magically melt away the pounds without any effort.The popularity of Ozempic has left fitness professionals and gym owners grappling with its impact on the industry.As fitness professionals, our primary focus is on promoting long-term health and well-being through exercise and proper nutrition.We believe in empowering individuals to make positive lifestyle changes, leading to lasting results and improved overall health.However, Ozempic's marketing strategy is luring people away from the path of hard work and dedication, making our job of educating them even more challenging.In this episode, Tim and Randy delve into the Ozempic effect, discussing its potential side effects, the real cost of the easy route, and why long-term fitness solutions are the key to lasting results.Key Takeaways- Ozempic for weight loss? (01:46)- The psychology of the fitness consumer (05:32)- The power of belief (07:00)- Why gym owners should be fighting Ozempic (12:11) Additional Resources- Business Accelerator Program winninggym.com/call- Learn more about The Iron Circle - Business Talk with Fitness Professionals Facebook group - Jump on a call with Randy---If you haven't already, please rate and review the podcast on Apple Podcasts!

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.